Nextech VI Oncology SCSp - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-08-14
4:44 pm
Sale
2026-06-3013GTYRA BIOSCIENCES INC
TYRA
Nextech VI Oncology SCSp3,553,585
6.000%
-502,276decrease
(-12.38%)
Filing
History
2024-11-14
5:47 pm
Purchase
2024-09-3013GTYRA BIOSCIENCES INC
TYRA
Nextech VI Oncology SCSp4,055,861
7.700%
1,537,279increase
(+61.04%)
Filing
History
2023-02-14
4:35 pm
Unchanged
2022-12-3113GARS PHARMACEUTICALS, INC
SPRY
Nextech VI Oncology SCSp1,910,029
2.000%
0
(Unchanged)
Filing
History